EV Biologics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2017	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Feb '26 Feb 19, 2026	Dec '17 Dec 31, 2017	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016	Jun '15 Jun 30, 2015	Jun '14 Jun 30, 2014
Market Capitalization	1	7	6	21	71	-
Market Cap Growth	-91.25%	6.82%	-70.36%	-71.13%	-	-
Enterprise Value	-	17	-14	0	68	-
Last Close Price	0.08	2.70	2.54	8.57	30.00	-
PE Ratio	-	-	-	-	8.21	-
PS Ratio	0.09	0.69	0.64	0.48	1.54	-
PB Ratio	0.02	0.15	1.64	1.83	1.53	-
P/TBV Ratio	0.02	0.16	3.69	2.26	1.71	-
P/FCF Ratio	-	-	-	-	17.02	-
P/OCF Ratio	-	-	3.93	1.55	11.49	-
EV/Sales Ratio	-	1.75	-	0.01	1.47	-
EV/EBITDA Ratio	-	-	-	0.09	4.66	-
EV/EBIT Ratio	-	106.82	-	0.16	5.29	-
EV/FCF Ratio	-	-	-	-	16.26	-
Debt / Equity Ratio	0.15	0.15	3.19	1.04	0.33	0.52
Debt / EBITDA Ratio	-	-	-	2.17	1.05	1.17
Debt / FCF Ratio	-	-	-	-	3.66	1.72
Net Debt / Equity Ratio	-0.14	-0.14	2.70	0.80	-0.02	-0.01
Net Debt / EBITDA Ratio	-	-	-3.09	1.67	-0.08	-0.02
Net Debt / FCF Ratio	-	-	-26.46	-0.38	-0.28	-0.03
Asset Turnover	-	-	0.27	0.75	0.63	0.70
Inventory Turnover	-	-	26.51	71.77	74.69	74.71
Quick Ratio	0.80	0.80	0.23	0.34	0.84	1.83
Current Ratio	3.11	3.11	0.30	0.42	0.87	1.97
Return on Equity (ROE)	-	-	-99.17%	-183.68%	20.59%	33.15%
Return on Assets (ROA)	-	-	-7.05%	3.49%	10.92%	15.02%
Return on Invested Capital (ROIC)	0.62%	0.62%	-23.11%	9.69%	23.28%	30.17%
Return on Capital Employed (ROCE)	0.40%	0.40%	-105.70%	28.20%	27.50%	27.20%
Earnings Yield	-65.62%	-8.47%	-121.91%	-258.71%	12.19%	-
FCF Yield	-	-	-6.22%	-113.55%	5.88%	-
Buyback Yield / Dilution	-0.69%	-	-1.02%	-49.09%	-	-

Updated Nov 15, 2017. Source: S&P Global Market Intelligence. Standard template. Financial Sources.